Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Aug;65(8):3337–3344. doi: 10.1128/iai.65.8.3337-3344.1997

Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB.

C B Louise 1, M C Tran 1, T G Obrig 1
PMCID: PMC175472  PMID: 9234795

Abstract

Infection of humans with Shiga toxin-producing Escherichia coli O157:H7 and Shigella dysenteriae 1 is strongly associated with vascular endothelial cell damage and the development of hemolytic-uremic syndrome. The cytotoxic effect of Shiga toxins on vascular endothelial cells in vitro is enhanced by prior exposure to bacterial lipopolysaccharide (LPS) or either of the host cytokines tumor necrosis factor alpha (TNF) and interleukin-1beta (IL-1). The purpose of this study was to examine individual signal transduction components involved in the sensitization of human umbilical vein endothelial cells (HUVEC) to Shiga toxin 1. The results demonstrate that class I and II protein kinase C (PKC) isozymes are required for sensitization of HUVEC to Shiga toxin by phorbol myristate acetate (PMA) or LPS but not by TNF or IL-1. Thus, the specific competitive inhibitor of class I/II PKC, 1-O-hexadecyl-2-O-methyl-rac-glycerol (AMG), prevented only the action of PMA and LPS on HUVEC. Additional data obtained with ATP binding site inhibitors which affect all PKCs (i.e., classes I, II, and III) suggest that TNF may utilize class III PKC isozymes in the Shiga toxin sensitization of HUVEC. Transcriptional activator NF-kappaB did not appear to be involved in the sensitization of HUVEC to Shiga toxin by LPS, TNF, IL-1, or PMA. Thus, the specific serine protease inhibitor L-1-tosylamido-2-phenylethyl chloromethyl ketone (TPCK) did not inhibit the sensitization of HUVEC to Shiga toxin by LPS, TNF, IL-1, or PMA despite its ability to inhibit NF-kappaB activation and the induction of the NF-kappaB-dependent tissue factor gene by these agents. Finally, all-trans retinoic acid partially inhibited the sensitization of HUVEC to Shiga toxin, by unknown mechanisms which also appeared to be independent of NF-kappaB activation. These results indicate that PKC plays a role in the sensitization of HUVEC to Shiga toxin in response to some, but not all, sensitizing agents. In contrast, NF-kappaB activation appears not to be involved in the sensitization of HUVEC to Shiga toxin by LPS, TNF, IL-1, or PMA.

Full Text

The Full Text of this article is available as a PDF (427.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bierhaus A., Zhang Y., Deng Y., Mackman N., Quehenberger P., Haase M., Luther T., Müller M., Böhrer H., Greten J. Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor. J Biol Chem. 1995 Nov 3;270(44):26419–26432. doi: 10.1074/jbc.270.44.26419. [DOI] [PubMed] [Google Scholar]
  2. Bradshaw D., Hill C. H., Nixon J. S., Wilkinson S. E. Therapeutic potential of protein kinase C inhibitors. Agents Actions. 1993 Jan;38(1-2):135–147. doi: 10.1007/BF02027225. [DOI] [PubMed] [Google Scholar]
  3. Bussolino F., Silvagno F., Garbarino G., Costamagna C., Sanavio F., Arese M., Soldi R., Aglietta M., Pescarmona G., Camussi G. Human endothelial cells are targets for platelet-activating factor (PAF). Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF. J Biol Chem. 1994 Jan 28;269(4):2877–2886. [PubMed] [Google Scholar]
  4. Crossman D. C., Carr D. P., Tuddenham E. G., Pearson J. D., McVey J. H. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem. 1990 Jun 15;265(17):9782–9787. [PubMed] [Google Scholar]
  5. Deisher T. A., Haddix T. L., Montgomery K. F., Pohlman T. H., Kaushansky K., Harlan J. M. The role of protein kinase C in the induction of VCAM-1 expression on human umbilical vein endothelial cells. FEBS Lett. 1993 Oct 4;331(3):285–290. doi: 10.1016/0014-5793(93)80354-w. [DOI] [PubMed] [Google Scholar]
  6. Deisher T. A., Sato T. T., Pohlman T. H., Harlan J. M. A protein kinase C agonist, selective for the beta I isozyme, induces E-selectin and VCAM-1 expression on HUVEC but does not translocate PKC. Biochem Biophys Res Commun. 1993 Jun 30;193(3):1283–1290. doi: 10.1006/bbrc.1993.1764. [DOI] [PubMed] [Google Scholar]
  7. Diaz-Meco M. T., Berra E., Municio M. M., Sanz L., Lozano J., Dominguez I., Diaz-Golpe V., Lain de Lera M. T., Alcamí J., Payá C. V. A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation. Mol Cell Biol. 1993 Aug;13(8):4770–4775. doi: 10.1128/mcb.13.8.4770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Diaz-Meco M. T., Dominguez I., Sanz L., Dent P., Lozano J., Municio M. M., Berra E., Hay R. T., Sturgill T. W., Moscat J. zeta PKC induces phosphorylation and inactivation of I kappa B-alpha in vitro. EMBO J. 1994 Jun 15;13(12):2842–2848. doi: 10.1002/j.1460-2075.1994.tb06578.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fesus L., Nagy L., Basilion J. P., Davies P. J. Retinoic acid receptor transcripts in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 1991 Aug 30;179(1):32–38. doi: 10.1016/0006-291x(91)91329-b. [DOI] [PubMed] [Google Scholar]
  10. Finco T. S., Beg A. A., Baldwin A. S., Jr Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):11884–11888. doi: 10.1073/pnas.91.25.11884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ghosh S., Baltimore D. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature. 1990 Apr 12;344(6267):678–682. doi: 10.1038/344678a0. [DOI] [PubMed] [Google Scholar]
  12. Griffin P. M., Tauxe R. V. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev. 1991;13:60–98. doi: 10.1093/oxfordjournals.epirev.a036079. [DOI] [PubMed] [Google Scholar]
  13. Grilli M., Chiu J. J., Lenardo M. J. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol. 1993;143:1–62. doi: 10.1016/s0074-7696(08)61873-2. [DOI] [PubMed] [Google Scholar]
  14. Haller H., Lindschau C., Luft F. C. Role of protein kinase C in intracellular signaling. Ann N Y Acad Sci. 1994 Sep 15;733:313–324. doi: 10.1111/j.1749-6632.1994.tb17281.x. [DOI] [PubMed] [Google Scholar]
  15. Henkel T., Machleidt T., Alkalay I., Krönke M., Ben-Neriah Y., Baeuerle P. A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature. 1993 Sep 9;365(6442):182–185. doi: 10.1038/365182a0. [DOI] [PubMed] [Google Scholar]
  16. Ishii H., Horie S., Kizaki K., Kazama M. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood. 1992 Nov 15;80(10):2556–2562. [PubMed] [Google Scholar]
  17. Kaye S. A., Louise C. B., Boyd B., Lingwood C. A., Obrig T. G. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect Immun. 1993 Sep;61(9):3886–3891. doi: 10.1128/iai.61.9.3886-3891.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Keusch G. T., Acheson D. W., Aaldering L., Erban J., Jacewicz M. S. Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells. J Infect Dis. 1996 May;173(5):1164–1170. doi: 10.1093/infdis/173.5.1164. [DOI] [PubMed] [Google Scholar]
  19. Kooistra T., Opdenberg J. P., Toet K., Hendriks H. F., van den Hoogen R. M., Emeis J. J. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo. Thromb Haemost. 1991 May 6;65(5):565–572. [PubMed] [Google Scholar]
  20. Koster F. T., Boonpucknavig V., Sujaho S., Gilman R. H., Rahaman M. M. Renal histopathology in the hemolytic-uremic syndrome following shigellosis. Clin Nephrol. 1984 Feb;21(2):126–133. [PubMed] [Google Scholar]
  21. Koster F., Levin J., Walker L., Tung K. S., Gilman R. H., Rahaman M. M., Majid M. A., Islam S., Williams R. C., Jr Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med. 1978 Apr 27;298(17):927–933. doi: 10.1056/NEJM197804272981702. [DOI] [PubMed] [Google Scholar]
  22. Kramer I. M., van der Bend R. L., Tool A. T., van Blitterswijk W. J., Roos D., Verhoeven A. J. 1-O-hexadecyl-2-Q-methylglycerol, a novel inhibitor of protein kinase C, inhibits the respiratory burst in human neutrophils. J Biol Chem. 1989 Apr 5;264(10):5876–5884. [PubMed] [Google Scholar]
  23. Krust A., Kastner P., Petkovich M., Zelent A., Chambon P. A third human retinoic acid receptor, hRAR-gamma. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5310–5314. doi: 10.1073/pnas.86.14.5310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lingwood C. A. Verotoxins and their glycolipid receptors. Adv Lipid Res. 1993;25:189–211. [PubMed] [Google Scholar]
  25. Louise C. B., Obrig T. G. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun. 1992 Apr;60(4):1536–1543. doi: 10.1128/iai.60.4.1536-1543.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Louise C. B., Obrig T. G. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun. 1991 Nov;59(11):4173–4179. doi: 10.1128/iai.59.11.4173-4179.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lozano J., Berra E., Municio M. M., Diaz-Meco M. T., Dominguez I., Sanz L., Moscat J. Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. J Biol Chem. 1994 Jul 29;269(30):19200–19202. [PubMed] [Google Scholar]
  28. Marui N., Offermann M. K., Swerlick R., Kunsch C., Rosen C. A., Ahmad M., Alexander R. W., Medford R. M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993 Oct;92(4):1866–1874. doi: 10.1172/JCI116778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mattila P., Majuri M. L., Tiisala S., Renkonen R. Expression of six protein kinase C isotypes in endothelial cells. Life Sci. 1994;55(16):1253–1260. doi: 10.1016/0024-3205(94)90063-9. [DOI] [PubMed] [Google Scholar]
  30. Medh R. D., Santell L., Levin E. G. Stimulation of tissue plasminogen activator production by retinoic acid: synergistic effect on protein kinase C-mediated activation. Blood. 1992 Aug 15;80(4):981–987. [PMC free article] [PubMed] [Google Scholar]
  31. Moll T., Czyz M., Holzmüller H., Hofer-Warbinek R., Wagner E., Winkler H., Bach F. H., Hofer E. Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J Biol Chem. 1995 Feb 24;270(8):3849–3857. doi: 10.1074/jbc.270.8.3849. [DOI] [PubMed] [Google Scholar]
  32. Montgomery K. F., Osborn L., Hession C., Tizard R., Goff D., Vassallo C., Tarr P. I., Bomsztyk K., Lobb R., Harlan J. M. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6523–6527. doi: 10.1073/pnas.88.15.6523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Newton A. C. Interaction of proteins with lipid headgroups: lessons from protein kinase C. Annu Rev Biophys Biomol Struct. 1993;22:1–25. doi: 10.1146/annurev.bb.22.060193.000245. [DOI] [PubMed] [Google Scholar]
  34. Niedbala M. J., Stein-Picarella M. Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator. Blood. 1993 May 15;81(10):2608–2617. [PubMed] [Google Scholar]
  35. Obrig T. G., Del Vecchio P. J., Brown J. E., Moran T. P., Rowland B. M., Judge T. K., Rothman S. W. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun. 1988 Sep;56(9):2373–2378. doi: 10.1128/iai.56.9.2373-2378.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Obrig T. G., Louise C. B., Lingwood C. A., Boyd B., Barley-Maloney L., Daniel T. O. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem. 1993 Jul 25;268(21):15484–15488. [PubMed] [Google Scholar]
  37. Parry G. C., Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem. 1994 Aug 19;269(33):20823–20825. [PubMed] [Google Scholar]
  38. Parry G. C., Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol. 1995 May;15(5):612–621. doi: 10.1161/01.atv.15.5.612. [DOI] [PubMed] [Google Scholar]
  39. Pfahl M. Nuclear receptor/AP-1 interaction. Endocr Rev. 1993 Oct;14(5):651–658. doi: 10.1210/edrv-14-5-651. [DOI] [PubMed] [Google Scholar]
  40. Pickering L. K., Obrig T. G., Stapleton F. B. Hemolytic-uremic syndrome and enterohemorrhagic Escherichia coli. Pediatr Infect Dis J. 1994 Jun;13(6):459–476. doi: 10.1097/00006454-199406000-00001. [DOI] [PubMed] [Google Scholar]
  41. Raghupathy P., Date A., Shastry J. C., Sudarsanam A., Jadhav M. Haemolytic-uraemic syndrome complicating shigella dystentery in south Indian children. Br Med J. 1978 Jun 10;1(6126):1518–1521. doi: 10.1136/bmj.1.6126.1518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ramegowda B., Tesh V. L. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect Immun. 1996 Apr;64(4):1173–1180. doi: 10.1128/iai.64.4.1173-1180.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Read M. A., Cordle S. R., Veach R. A., Carlisle C. D., Hawiger J. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9887–9891. doi: 10.1073/pnas.90.21.9887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Read M. A., Whitley M. Z., Williams A. J., Collins T. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med. 1994 Feb 1;179(2):503–512. doi: 10.1084/jem.179.2.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ritchie A. J., Johnson D. R., Ewenstein B. M., Pober J. S. Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. Studies with phorbol myristate acetate and staurosporine. J Immunol. 1991 May 1;146(9):3056–3062. [PubMed] [Google Scholar]
  46. Schütze S., Machleidt T., Krönke M. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J Leukoc Biol. 1994 Nov;56(5):533–541. doi: 10.1002/jlb.56.5.533. [DOI] [PubMed] [Google Scholar]
  47. Simonson M. S. Anti-AP-1 activity of all-trans retinoic acid in glomerular mesangial cells. Am J Physiol. 1994 Nov;267(5 Pt 2):F805–F815. doi: 10.1152/ajprenal.1994.267.5.F805. [DOI] [PubMed] [Google Scholar]
  48. Slootweg M. C., de Groot R. P., Herrmann-Erlee M. P., Koornneef I., Kruijer W., Kramer Y. M. Growth hormone induces expression of c-jun and jun B oncogenes and employs a protein kinase C signal transduction pathway for the induction of c-fos oncogene expression. J Mol Endocrinol. 1991 Apr;6(2):179–188. doi: 10.1677/jme.0.0060179. [DOI] [PubMed] [Google Scholar]
  49. Surprenant Y. M., Zuckerman S. H. A novel microtiter plate assay for the quantitation of procoagulant activity on adherent monocytes, macrophage and endothelial cells. Thromb Res. 1989 Feb 1;53(3):339–346. doi: 10.1016/0049-3848(89)90108-4. [DOI] [PubMed] [Google Scholar]
  50. Terry C. M., Callahan K. S. Protein kinase C regulates cytokine-induced tissue factor transcription and procoagulant activity in human endothelial cells. J Lab Clin Med. 1996 Jan;127(1):81–93. doi: 10.1016/s0022-2143(96)90169-9. [DOI] [PubMed] [Google Scholar]
  51. Tesh V. L., Samuel J. E., Perera L. P., Sharefkin J. B., O'Brien A. D. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis. 1991 Aug;164(2):344–352. doi: 10.1093/infdis/164.2.344. [DOI] [PubMed] [Google Scholar]
  52. Umesono K., Murakami K. K., Thompson C. C., Evans R. M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell. 1991 Jun 28;65(7):1255–1266. doi: 10.1016/0092-8674(91)90020-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. van Blitterswijk W. J., van der Bend R. L., Kramer I. M., Verhoeven A. J., Hilkmann H., de Widt J. A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C. Lipids. 1987 Nov;22(11):842–846. doi: 10.1007/BF02535541. [DOI] [PubMed] [Google Scholar]
  54. van Setten P. A., Monnens L. A., Verstraten R. G., van den Heuvel L. P., van Hinsbergh V. W. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood. 1996 Jul 1;88(1):174–183. [PubMed] [Google Scholar]
  55. van de Kar N. C., Kooistra T., Vermeer M., Lesslauer W., Monnens L. A., van Hinsbergh V. W. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C. Blood. 1995 Feb 1;85(3):734–743. [PubMed] [Google Scholar]
  56. van de Kar N. C., Monnens L. A., Karmali M. A., van Hinsbergh V. W. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood. 1992 Dec 1;80(11):2755–2764. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES